166 related articles for article (PubMed ID: 30063374)
1. Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions.
Mori N; Pineda FD; Tsuchiya K; Mugikura S; Takahashi S; Karczmar GS; Abe H
AJR Am J Roentgenol; 2018 Oct; 211(4):933-939. PubMed ID: 30063374
[TBL] [Abstract][Full Text] [Related]
2. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
Mori N; Sheth D; Abe H
AJR Am J Roentgenol; 2020 Aug; 215(2):511-518. PubMed ID: 32452698
[No Abstract] [Full Text] [Related]
3. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
4. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.
Abe H; Mori N; Tsuchiya K; Schacht DV; Pineda FD; Jiang Y; Karczmar GS
AJR Am J Roentgenol; 2016 Nov; 207(5):1159-1166. PubMed ID: 27532897
[TBL] [Abstract][Full Text] [Related]
5. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density.
Mori N; Abe H; Mugikura S; Takasawa C; Sato S; Miyashita M; Mori Y; Pineda FD; Karczmar GS; Tamura H; Takahashi S; Takase K
Acad Radiol; 2019 Jul; 26(7):e141-e149. PubMed ID: 30269956
[TBL] [Abstract][Full Text] [Related]
6. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
[TBL] [Abstract][Full Text] [Related]
7. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.
Partridge SC; Stone KM; Strigel RM; DeMartini WB; Peacock S; Lehman CD
Acad Radiol; 2014 Sep; 21(9):1195-203. PubMed ID: 24998690
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of diffusion kurtosis imaging in the differentiation of malignant from benign breast lesions.
Liu W; Wei C; Bai J; Gao X; Zhou L
Eur J Radiol; 2019 Aug; 117():156-163. PubMed ID: 31307642
[TBL] [Abstract][Full Text] [Related]
9. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
10. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
[TBL] [Abstract][Full Text] [Related]
12. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
[TBL] [Abstract][Full Text] [Related]
14. DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?
Jansen SA; Fan X; Karczmar GS; Abe H; Schmidt RA; Giger M; Newstead GM
Med Phys; 2008 Jul; 35(7):3102-9. PubMed ID: 18697535
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience using dynamic MRI at 3.0 Tesla for evaluation of soft tissue tumors.
Park MY; Jee WH; Kim SK; Lee SY; Jung JY
Korean J Radiol; 2013; 14(1):102-9. PubMed ID: 23323039
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI.
Mori N; Tsuchiya K; Sheth D; Mugikura S; Takase K; Katscher U; Abe H
Eur Radiol; 2019 Apr; 29(4):1778-1786. PubMed ID: 30255252
[TBL] [Abstract][Full Text] [Related]
18. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
[TBL] [Abstract][Full Text] [Related]
19. Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.
Jansen SA; Shimauchi A; Zak L; Fan X; Wood AM; Karczmar GS; Newstead GM
AJR Am J Roentgenol; 2009 Sep; 193(3):832-9. PubMed ID: 19696299
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
